Recordati Rare Diseases Canada Inc. announced today the Canadian product availability of ISTURISA® (osilodrostat) for the treatment of adult patients with Cushing's disease who have persistent or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback